Tectonic Therapeutic, Inc. (TECX)
NASDAQ: TECX · Real-Time Price · USD
23.45
-0.48 (-2.01%)
Feb 27, 2026, 4:00 PM EST - Market closed
Tectonic Therapeutic Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Tectonic Therapeutic stock have an average target of 80.4, with a low estimate of 60 and a high estimate of 101. The average target predicts an increase of 242.86% from the current stock price of 23.45.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jan 8, 2026.
Analyst Ratings
The average analyst rating for Tectonic Therapeutic stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 5 | 5 | 5 | 5 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Maintains $64 → $60 | Strong Buy | Maintains | $64 → $60 | +155.86% | Jan 8, 2026 |
| Oppenheimer | Oppenheimer | Buy Initiates $80 | Buy | Initiates | $80 | +241.15% | Sep 3, 2025 |
| Truist Securities | Truist Securities | Strong Buy Initiates $64 | Strong Buy | Initiates | $64 | +172.92% | Jul 21, 2025 |
| Raymond James | Raymond James | Buy Initiates $76 | Buy | Initiates | $76 | +224.09% | Jun 11, 2025 |
| Mizuho | Mizuho | Buy Maintains $51 → $85 | Buy | Maintains | $51 → $85 | +262.47% | May 15, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-4.19
from -6.83
EPS Next Year
-4.85
from -4.19
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -4.19 | -4.03 | |
| Avg | -4.19 | -4.85 | |
| Low | -4.12 | -5.34 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.